Contact

huurders


Okklo Life Sciences

Okklo Life Sciences is a privately held biopharmaceutical company developing novel therapeutic solutions using cyclodextrin-based technologies, with a focus on neglected and orphan diseases.
The company was founded in December 2011 by a team of life-sciences experts previously involved in the development and approval of sugammadex (Bridion™), the first modified cyclodextrin (CD) marketed as a drug product.

Voor meer informatie klik hier

Inloggen beleggers
Inloggen huurders